Johnson & Johnson, AstraZeneca COVID-19 Vaccine Developers Claim Modifications Could Reduce Blood Clotting Risk Johnson & Johnson developers, as well as the creators of AstraZeneca, are now considering modifying their COVID-19 vaccines. by Griffin Davis
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study